导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -25.90% | 1031/1050 |
| 近一周 | -1.67% | 284/1104 |
| 近一月 | -9.16% | 1000/1102 |
| 近一季 | -6.81% | 511/1092 |
| 近半年 | -19.65% | 980/1070 |
| 近一年 | -29.54% | 983/1018 |
| 近两年 | -8.28% | 914/926 |
| 近三年 | -46.07% | 829/834 |
| 成立以来 | -9.74% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-11.11% 1019/1070 |
-17.30% 1050/1101 |
- - |
- - |
| 2025 | -3.61% 942/1065 |
-2.79% 940/1014 |
-8.60% 997/1038 |
8.88% 866/1050 |
-0.37% 477/1065 |
| 2024 | -11.47% 796/1011 |
-2.60% 453/960 |
-15.36% 944/983 |
17.70% 112/991 |
-8.76% 859/1011 |
| 2023 | -17.94% 620/952 |
9.13% 138/880 |
-16.89% 868/895 |
2.82% 24/915 |
-12.00% 901/952 |
| 2022 | -14.88% 168/867 |
-23.16% 673/773 |
21.60% 15/806 |
-14.24% 522/845 |
6.22% 158/867 |
| 2021 | 42.50% 31/740 |
-3.50% 282/580 |
32.31% 46/659 |
5.70% 114/704 |
5.59% 204/740 |
| 2020 | - - |
- - |
- - |
- - |
15.23% 199/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 北信瑞丰优选成长 VS. 东吴新产业精选股票A(580008) |